Search
News Archive
Categories
EHSI Signs Option Agreement with Stem Cell Tech Developers OceanBASIS
Posted On: January 19, 2011Emerging Healthcare Solutions, Inc. (PinkSheets:EHSI.pk) announced recently that it has entered into an option agreement with OceanBASIS, a German company specializing in stem-cell and marine-collagen technologies and products.
During the 60-day option period, EHSI will conduct a due-diligence review of OceanBASIS and its prospects in order to negotiate a potential profit-sharing agreement. OceanBASIS is a biotech firm dedicated to developing and marketing sustainably derived marine natural products for the health and cosmetic industries. The company’s top projects under development include a bone scaffold designed for use as a stem cell matrix in cartilage repairing surgeries and a wound gel intended to improve healing of chronic wounds. Both products are derived from marine collagen, a purer form than the bovine collagen currently being used.
“OceanBASIS is working on the cutting edge of regenerative medicine, and we look forward to negotiating a definitive agreement with them soon,” said EHSI President and CEO Cindy Morrissey.
The burgeoning relationship between Emerging Healthcare Solutions and OceanBASIS is a result of EHSI’s recent efforts to expand its global reach, including the establishment of a business office in Frankfurt, Germany, in November that will allow EHSI to maintain long-term relationships with some of the world’s foremost stem cell researchers in Central and Western Europe.
Chinese Marine Collagen marketing in US and Europe
Posted On: November 11, 2009Chinese supplier Fenchem said its new collagen peptide extracted from fish scales, an ingredient used in the joint health food and drinks market in Japan, is aimed at food and supplement manufacturers in the US and Europe.
China’s first flow production line for the comprehensive processing of fish scales put into use in Shanghai
Posted On: June 11, 2009China’s first flow production line for the comprehensive processing of fish scales, developed by Shanghai Fisheries Research Institute, was put into use. This line can “eat up” 40-50 tons per month of residual fish scales from aquatic products processing operations and turn out a series of highly value-added processed products, such as collagen protein, gelatin, animal feeds. The technology is internationally advanced and capable of being industrialized. It was estimated that the line will generate an economic benefit of 25 thousand RMB yuan from every ton of fish scales.
Excerpted and translated from China Ocean Newspaper dated June, 20th, 2008, by Haiping Zhang.










